*<p>Defined as the presence of a hypoxic period (SpO<sub>2</sub><95%) for >10% of the total sleep time.</p><p>Abbreviation: ALSFRSr = Amyotrophic Lateral Sclerosis Functional Rating Scale Revised, ETCO<sub>2</sub> = end-tidal carbon dioxide, FVC = forced vital capacity, SpO<sub>2</sub> = arterial oxygen saturation measured using pulse oximetry, cluster of desaturation ≥5 desaturations (a decrease in SpO<sub>2</sub>≥4%) within a 10-min period.</p><p>All continuous values are expressed as mean ± standard deviation.</p
Objective: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that causes sk...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting both the central and p...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
*<p>Defined as the presence of a hypoxic period (SpO<sub>2</sub><95%) for >10% of the total sleep ti...
Background and purpose Respiratory insufficiency and its complications are the main cause of death i...
PURPOSE: To evaluate the initial respiratory impairments [pulmonary functions and arterial blood gas...
Introduction: Respiratory function is a critical predictor of survival in amyotrophic lateral sclero...
The aim of this study was to evaluate the time course of breathing pattern and respiratory mechanics...
IMPORTANCE The prognostic value of slow vital capacity (SVC) in relation to respiratory function dec...
ackgroundHypoventilation due to respiratory insufficiency is the most common cause of death in amyot...
<div><p>Background</p><p>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that lea...
Objective: To examine whether the responses to standard sleep questionnaires used in ALS correlate w...
Amyotrophic Lateral Sclerosis is a neurodegenerative disease, mostly due to progressive loss of moto...
a<p>Progression rate = (40-ALSFRS)/disease duration (months).</p>b<p>ALSFRS-ALS functional rating sc...
Objective: to evaluate the rate of sleep disorders of insomnia type among patients with amyotrophic ...
Objective: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that causes sk...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting both the central and p...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...
*<p>Defined as the presence of a hypoxic period (SpO<sub>2</sub><95%) for >10% of the total sleep ti...
Background and purpose Respiratory insufficiency and its complications are the main cause of death i...
PURPOSE: To evaluate the initial respiratory impairments [pulmonary functions and arterial blood gas...
Introduction: Respiratory function is a critical predictor of survival in amyotrophic lateral sclero...
The aim of this study was to evaluate the time course of breathing pattern and respiratory mechanics...
IMPORTANCE The prognostic value of slow vital capacity (SVC) in relation to respiratory function dec...
ackgroundHypoventilation due to respiratory insufficiency is the most common cause of death in amyot...
<div><p>Background</p><p>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that lea...
Objective: To examine whether the responses to standard sleep questionnaires used in ALS correlate w...
Amyotrophic Lateral Sclerosis is a neurodegenerative disease, mostly due to progressive loss of moto...
a<p>Progression rate = (40-ALSFRS)/disease duration (months).</p>b<p>ALSFRS-ALS functional rating sc...
Objective: to evaluate the rate of sleep disorders of insomnia type among patients with amyotrophic ...
Objective: Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that causes sk...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting both the central and p...
<p>ALS, amyotrophic lateral sclerosis; ALSFRS-R, revised ALS functional rating scale; ALSSS, ALS sev...